vimarsana.com

Page 7 - தேசிய மருத்துவ மேலாண்மை ப்ரோடொகால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Explained: What has led to a crippling shortage of Remdesivir | India News

NEW DELHI: Amid an unprecedented surge in fresh Covid-19 infections, multiple states, including Maharashtra, Gujarat and Delhi, have flagged a shortage of anti-viral drug Remdesivir. The shortage prompted the government to halt the export of the drug and Remdesivir active pharmaceutical ingredients (APIs) till the Covid spread is contained. As the country witnesses a ferocious resurgence of the virus, so has the demand for this medicine. Here are a few questions answered on the use of Remdesivir for Covid treatment and problems in the supply chain management. How did Remdesivir come into use? Remdesivir is an investigational antiviral drug to fight Sars-Cov 2, the virus that causes Covid-19. The US Food and Drug Administration (FDA) approved Gilead Sciences Inc’s antiviral therapy Remdesivir in October 2020, making it the first drug to obtain formal clearance for treating the coronavirus disease.

Remdesivir not for home use, meant for serious patients, says Govt amid rise in demand

Remdesivir not for home use, meant for serious patients, says Govt amid rise in demand SECTIONS Last Updated: Apr 13, 2021, 08:04 PM IST Share Synopsis At a weekly press conference, NITI Aayog member (Health) Dr V K Paul said, Remdesivir is to be used only in those who require hospitalisation and are on oxygen support. That is the precondition. There is no question of its use in the home setting and for mild cases, and it is not to be procured from chemist shops. Agencies Remdesivir is listed for use in serious COVID-19 patients in the Clinical Management Protocols for COVID-19 as an investigational therapy.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.